Literature DB >> 27879491

18F-FDG PET/CT in Renal Infections: Evidence of Acute Pyelonephritis in a Horseshoe Kidney.

Maxime Morelle1, Alice Jaillard, Dimitri Bellevre, Guillaume Collet, Grégory Petyt.   

Abstract

A 58-year-old paraplegic patient was prescribed F-FDG for persistent inflammatory syndrome after aortic surgery for dissection. The examination was performed on a Siemens mCT Flow PET/CT and shows a moderate prostate uptake, related to prostatitis on self-catheterization and a focal renal cortical hypermetabolism of the left medial midpole of a horseshoe kidney, which corresponds to renal parenchyma on the CT, and suggests pyelonephritis, confirmed by Tc-DMSA SPECT/CT.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 27879491     DOI: 10.1097/RLU.0000000000001455

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


  4 in total

1.  Clinical utility of FDG PET/CT in acute complicated pyelonephritis-results from an observational study.

Authors:  Chih-Hsing Wan; Jing-Ren Tseng; Ming-Hsun Lee; Lan-Yan Yang; Tzu-Chen Yen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-09-26       Impact factor: 9.236

2.  Sulforaphane elicts dual therapeutic effects on Renal Inflammatory Injury and crystal deposition in Calcium Oxalate Nephrocalcinosis.

Authors:  Haoran Liu; Xiaoqi Yang; Kun Tang; Tao Ye; Chen Duan; Peng Lv; Libin Yan; Xiaoliang Wu; Zhiqiang Chen; Jianhe Liu; Yaoliang Deng; Guohua Zeng; Jinchun Xing; Zhangqun Ye; Hua Xu
Journal:  Theranostics       Date:  2020-06-05       Impact factor: 11.556

3.  Localization of acute pyelonephritis in pyrexia of unknown origin using FDG PET/CT.

Authors:  Shrikant Solav; Shailendra Savale; Abhijit Mahaveer Patil
Journal:  Asia Ocean J Nucl Med Biol       Date:  2020

4.  AhR activation attenuates calcium oxalate nephrocalcinosis by diminishing M1 macrophage polarization and promoting M2 macrophage polarization.

Authors:  Xiaoqi Yang; Haoran Liu; Tao Ye; Chen Duan; Peng Lv; Xiaoliang Wu; Jianhe Liu; Kehua Jiang; Hongyan Lu; Huan Yang; Ding Xia; Ejun Peng; Zhiqiang Chen; Kun Tang; Zhangqun Ye
Journal:  Theranostics       Date:  2020-10-25       Impact factor: 11.556

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.